High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism
- PMID: 17554059
- DOI: 10.1182/blood-2007-02-072405
High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism
Abstract
In allogenic hematopoietic stem-cell transplantation, an effect of HLA locus mismatch in allele level on clinical outcome has been clarified. However, the effect of each HLA allele mismatch combination is little known, and its molecular mechanism to induce acute graft-versus-host disease (aGVHD) remains to be elucidated. A total of 5210 donor-patient pairs who underwent transplantation through Japan Marrow Donor Program were analyzed. All HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1 alleles were retrospectively typed in all pairs. The impacts of the HLA allele mismatch combinations and amino acid substitution positions in 6 HLA loci on severe aGVHD were analyzed. A total of 15 significant high-risk HLA allele mismatch combinations and 1 HLA-DRB1-DQB1 linked mismatch combinations (high-risk mismatch) for severe aGVHD were identified, and the number of high-risk mismatches was highly associated with the occurrence of severe aGVHD regardless of the presence of mismatch combinations other than high-risk mismatch. Furthermore, 6 specific amino acid substitution positions in HLA class I were identified as those responsible for severe aGVHD. These findings provide evidence to elucidate the mechanism of aGVHD on the basis of HLA molecule. Furthermore, the identification of high-risk mismatch, that is, nonpermissive mismatch, would be beneficial for the selection of a suitable donor.
Similar articles
-
Predictions in the face of clinical reality: HistoCheck versus high-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease.Biol Blood Marrow Transplant. 2011 Sep;17(9):1409-15. doi: 10.1016/j.bbmt.2011.01.015. Epub 2011 Feb 4. Biol Blood Marrow Transplant. 2011. PMID: 21296176
-
[The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].Zhonghua Xue Ye Xue Za Zhi. 2012 May;33(5):353-7. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22781790 Chinese.
-
HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.Biol Blood Marrow Transplant. 2007 Aug;13(8):965-74. doi: 10.1016/j.bbmt.2007.04.010. Biol Blood Marrow Transplant. 2007. PMID: 17640601
-
Effect of HLA mismatch on acute graft-versus-host disease.Int J Hematol. 2013 Sep;98(3):300-8. doi: 10.1007/s12185-013-1405-x. Epub 2013 Jul 28. Int J Hematol. 2013. PMID: 23893313 Review.
-
[Implications of HLA in allogeneic stem cell transplantation].Rinsho Ketsueki. 2019;60(9):1324-1330. doi: 10.11406/rinketsu.60.1324. Rinsho Ketsueki. 2019. PMID: 31597859 Review. Japanese.
Cited by
-
Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.Korean J Intern Med. 2009 Dec;24(4):287-98. doi: 10.3904/kjim.2009.24.4.287. Epub 2009 Nov 27. Korean J Intern Med. 2009. PMID: 19949725 Free PMC article. Review.
-
Role of non-HLA gene polymorphisms in graft-versus-host disease.Int J Hematol. 2013 Sep;98(3):309-18. doi: 10.1007/s12185-013-1416-7. Epub 2013 Aug 15. Int J Hematol. 2013. PMID: 23949916 Review.
-
IL2rg Cytokines Enhance Umbilical Cord Blood CD34+ Cells Differentiation to T Cells.Adv Pharm Bull. 2015 Dec;5(Suppl 1):615-9. doi: 10.15171/apb.2015.083. Epub 2015 Dec 31. Adv Pharm Bull. 2015. PMID: 26793606 Free PMC article.
-
Allorecognition of HLA-C Mismatches by CD8+ T Cells in Hematopoietic Stem Cell Transplantation Is a Complex Interplay between Mismatched Peptide-Binding Region Residues, HLA-C Expression, and HLA-DPB1 Disparities.Front Immunol. 2016 Dec 12;7:584. doi: 10.3389/fimmu.2016.00584. eCollection 2016. Front Immunol. 2016. PMID: 28018351 Free PMC article.
-
Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation.Biol Blood Marrow Transplant. 2012 May;18(5):739-46. doi: 10.1016/j.bbmt.2011.09.008. Epub 2011 Sep 29. Biol Blood Marrow Transplant. 2012. PMID: 21963622 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials